Skip to main content
Equibles

Epoch Investment Partners, Inc.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1305841 New York, NY
Back to HALO Full portfolio

Position in HALO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$85,982,098
+$12,408,794 QoQ
Shares Held
1,098,532
-3.5% QoQ
Ownership
0.968%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#34
of 667 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Epoch Investment Partners, Inc. holds $202,712,087 across 3 Biotechnology names. HALO ranks #2 (42.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 186,850 $116,508,448
2 HALO
Halozyme Therapeutics, Inc.
This page 		1,098,532 $85,982,098
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 446 $221,541

All Filings in HALO

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $85,982,098 1,098,532
2026-03-31 $73,573,304 1,138,377
2025-12-31 $35,895,060 533,359
2025-09-30 $43,755,084 596,606
2025-06-30 $32,870,449 631,881
2025-03-31 $52,786,631 827,247
2024-12-31 $37,211,048 778,311
2024-09-30 $48,841,003 853,267
2024-06-30 $75,191,159 1,436,042
2024-03-31 $58,319,336 1,433,612
2023-12-31 $42,985,699 1,163,033
2023-09-30 $12,676,058 331,834
2023-06-30 $11,972,859 331,934
2023-03-31 $12,676,559 331,934
2022-12-31 $10,717,342 188,354